Product Information
CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB is a generic product labeled by Sandoz Inc., priced at $0.6200 per EA under NDC 00781563701. Its NADAC has been published 619 times since Aug 20, 2014.
Strength
25; 200; 100 mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781563701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; ENTACAPONE; LEVODOPAApproval Type
Authorized Generic (NDA)
FDA Application
NDA021485On Market Since
6/18/2014
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB has been published 619 times since Aug 20, 2014, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6200 per EA |
|---|---|
| All-time high | $2.5606 (Oct 15, 2014) |
| All-time low | $0.6107 (May 20, 2026) |
| 52-week high | $0.7317 |
| 52-week low | $0.6107 |
| Median price | $1.1227 |
| Average price | $1.2347 |
| Largest weekly change | +108.6% (Jul 21, 2021) |
| Weeks tracked | 619 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Carbidopa, Levodopa, and Entacapone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB, manufactured by Sandoz Inc., is $0.6200 per EA (NDC 00781563701), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB has declined 73.8%. It has been tracked across 619 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB?
Since Aug 20, 2014, the NADAC for CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB has ranged from a low of $0.6107 (May 20, 2026) to a high of $2.5606 (Oct 15, 2014), with a median of $1.1227 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB?
CARBIDOPA-LEVODOPA-ENTACAPONE 25-100-200 MG TAB (NDC 00781563701) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification